Bridging historical evidence and contemporary strategies in the adjuvant treatment of early-stage epithelial ovarian cancer
Open Access
- 9 October 2025
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 35 (12) , 102709
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic SubgroupsLaboratory Investigation, 2023
- Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomesGynecologic Oncology, 2018
- Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohortGynecologic Oncology, 2017
- Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers InitiativeEuropean Journal of Cancer, 2015
- 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancerGynecologic Oncology, 2014
- A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group StudyGynecologic Oncology, 2011
- The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group studyGynecologic Oncology, 2010
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneumGynecologic Oncology, 2008
- Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group studyGynecologic Oncology, 2006